Reckitt Benckiser Group (LON:RB) Stock Rating Reaffirmed by Deutsche Bank

Reckitt Benckiser Group (LON:RB)‘s stock had its “buy” rating reiterated by equities researchers at Deutsche Bank in a note issued to investors on Wednesday, ThisIsMoney.Co.Uk reports.

Other research analysts have also issued reports about the company. UBS Group reissued a “neutral” rating and set a GBX 6,500 ($84.93) price target on shares of Reckitt Benckiser Group in a research report on Tuesday. Jefferies Financial Group set a GBX 5,550 ($72.52) price target on Reckitt Benckiser Group and gave the company a “sell” rating in a research report on Tuesday. HSBC set a GBX 7,700 ($100.61) price target on Reckitt Benckiser Group and gave the company a “buy” rating in a research report on Thursday, October 10th. Liberum Capital reissued a “buy” rating on shares of Reckitt Benckiser Group in a research report on Tuesday. Finally, Sanford C. Bernstein set a GBX 7,600 ($99.31) price target on Reckitt Benckiser Group and gave the company a “buy” rating in a research report on Friday, October 18th. Four analysts have rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of GBX 6,865.88 ($89.71).

Shares of Reckitt Benckiser Group stock opened at GBX 5,805.04 ($75.85) on Wednesday. The company has a quick ratio of 0.43, a current ratio of 0.59 and a debt-to-equity ratio of 85.08. The firm has a market cap of $41.12 billion and a price-to-earnings ratio of 29.14. The business has a fifty day simple moving average of GBX 6,231.76 and a 200-day simple moving average of GBX 6,259.78. Reckitt Benckiser Group has a fifty-two week low of GBX 5,510 ($72.00) and a fifty-two week high of GBX 6,796 ($88.80).

In related news, insider Adrian Nevil Hennah sold 81,063 shares of the stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of GBX 6,399 ($83.61), for a total transaction of £5,187,221.37 ($6,778,023.48).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Article: Holder of Record

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit